Recent studies have demonstrated that CBD, either alone or in combination with tetrahydrocannabinol (THC), can restore physiological GLP-1 levels in murine models of colitis [16,43], suggesting a broader therapeutic role for cannabinoids in modulating gut hormone pathways and inflammation in colitis. Here, GLP1R is linked to colitis.